Six-Month Pulmonary Function After Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Patients
OBJECTIVES:. Venovenous extracorporeal membrane oxygenation has been largely used in patients with refractory acute respiratory distress syndrome due to coronavirus disease 2019. Few data on long-term pulmonary function among venovenous extracorporeal membrane oxygenation survivors are available. DE...
Main Authors: | Amédée Ego, MD, Olivier Taton, MD, Alexandre Brasseur, MD, Yves Laurent, MD, Fabio Silvio Taccone, MD, PhD, Romain Courcelle, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-07-01
|
Series: | Critical Care Explorations |
Online Access: | http://journals.lww.com/10.1097/CCE.0000000000000494 |
Similar Items
-
Argatroban for Anticoagulation in Patients Requiring Venovenous Extracorporeal Membrane Oxygenation in Coronavirus Disease 2019
by: Lauren A. Sattler, MD, et al.
Published: (2021-09-01) -
Awake Venovenous Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 Acute Respiratory Failure
by: Nawaporn Assanangkornchai, MD, FRCPT, et al.
Published: (2021-07-01) -
Racial disparities among patients on venovenous extracorporeal membrane oxygenation in the pre–Coronavirus Disease 2019 and Coronavirus Disease 2019 eras: A retrospective registry reviewCentral MessagePerspective
by: Zachary Obinna Enumah, MD, MA, et al.
Published: (2024-02-01) -
Right Ventricular Failure Following Patent Foramen Ovale Closure on Venovenous-Extracorporeal Membrane Oxygenation
by: Robert A. Hull, MD, et al.
Published: (2020-12-01) -
Volatile Sedation for Acute Respiratory Distress Syndrome Patients on Venovenous Extracorporeal Membrane Oxygenation and Ultraprotective Ventilation
by: Giacomo Grasselli, MD, et al.
Published: (2021-01-01)